NK cells are innate immune eff ector cells that secrete cytokines and acquire cytolytic function within hours of viral infections. The activation of NK cells is regulated by the balance of inhibitory and activating signals and is dependent on DCs, cytokines, and co-stimulatory molecules ( 1 -3 ) . NK cell responses to microbes are triggered by Toll-like receptor (TLR) ligands, which stimulate secretion of type I IFNs that in turn support IL-15 and IL-15R ␣ production ( 4 -6 ).
IL-15 and its proprietary receptor IL-15R ␣ are both essential for supporting NK cell homeostasis ( 7 ) . An unusual aspect of IL-15 and IL-15R ␣ binding is the extraordinarily high affi nity with which these proteins interact ( ‫ف‬ 5 × 10 Ϫ 11 M) ( 8, 9 ) . Another notable observation is that the phenotypes of IL-15 (IL-15 Ϫ / Ϫ ) and IL-15R ␣ (IL-15R ␣ Ϫ / Ϫ ) -defi cient mice are indistinguishable, suggesting that physiologically relevant IL-15 signals require IL-15R ␣ and that these molecules function in close cooperation ( 10, 11 ) . On the other hand, some studies have reported secretion of soluble IL-15, and the ability of recombinant IL-15 to stimulate cells bearing IL-2/15R ␤ and ␥ c but lacking IL-15R ␣ raises questions about whether and when IL-15 may perform IL-15R ␣ -independent functions. Additional questions surrounding IL-15 and IL-15R ␣ biology relate to the observations that IL-15 cDNAs are difficult to express heterologously unless leader sequences, ATG sites, and 3 Ј mRNA sequences are altered ( 12 ) . These fi ndings suggest that complex intracellular processing regulates the bioavailability of IL-15.
Prior studies from our laboratory showed that IL-15R ␣ functions in an unexpected noncell-autonomous fashion in vivo ( 13 -15 ) . IL-15R ␣ expression on responding cells does not enhance the responsiveness of IL-15 -dependent cells in vivo ( 13 -16 ) . Soluble IL-15 can bind to IL-15R ␣ on accessory cells that " trans present " IL-15 to responding cells in vitro ( 17 ) .
Negligible levels of IL-15R ␣ were detected in cell lysates from nonstimulated bone marrow -derived DCs (BMDCs), and IL-15R ␣ protein levels were similarly induced in lysates from WT or IL-15 Ϫ / Ϫ cell BMDCs (but not IL-15R ␣ Ϫ / Ϫ cells) between 2 and 12 h ( Fig. 1 A ) . Hence, IL-15R ␣ is induced in DCs by TLR stimulation, and IL-15 does not infl uence the production of IL-15R ␣ .
Somewhat surprisingly, IL-15 protein was only transiently detected at modest levels within IL-15R ␣ Ϫ / Ϫ BMDCs and not at all in WT cells ( Fig. 1 B ) . This occurred despite the fact that IL-15 mRNA levels, detected by real-time PCR, were markedly induced by poly I:C in both IL-15R ␣ Ϫ / Ϫ and WT BMDCs (unpublished data). To understand why IL-15 protein was not detected in WT cells, we hypothesized that IL-15 in WT cells might be complexed with IL-15R ␣ protein. As noted above, epitopes of IL-15 detected by several anti -IL-15 antibodies are blocked by high affi nity interactions between IL-15 and IL-15R ␣ . To investigate whether IL-15 is complexed with IL-15R ␣ in poly I:C -stimulated BMDCs, we established conditions to dissociate these proteins without denaturing them before ELISA analyses. We boiled lysates from poly I:C -stimulated BMDCs in the presence of 0.01% SDS before analyzing IL-15 protein levels by ELISA. These experiments showed that IL-15 protein was indeed induced in WT cells at nanomolar levels in parallel with the induction of IL-15R ␣ ( Fig. 1 C ) . Similar results were obtained with LPS stimulation of DCs (unpublished data). Thus, IL-15 is induced by TLR stimulation and appears to be predominantly bound to another protein (e.g., IL-15R ␣ ) inside DCs.
To further examine the possibility that endogenous IL-15 and IL-15R ␣ proteins exist in complexes in normal BMDCs, we developed a " complex " ELISA in which an anti -IL-15 antibody that detects IL-15 in the presence of IL-15R ␣ was Trans presentation in vivo requires expression of IL-15 and IL-15R ␣ by hematopoietic accessory cells and expression of IL-2/15R ␤ by IL-15 -responsive NK cells and memory CD8 + T cells ( 18 ) . Trans presentation appears to be the dominant mechanism by which IL-15 signals are delivered in vivo ( 13 -16, 18 ) .
Why IL-15 signals should be delivered via this somewhat complicated trans presentation mechanism is unclear. Some clues have been provided by recent studies revealing that coordinate expression of IL-15 and IL-15R ␣ by the same accessory cells such as DCs is required for supporting both NK and CD8 + memory T cell homeostasis ( 18, 19 ) . These results are not consistent with a mechanism in which IL-15 is secreted by DCs and subsequently bound to IL-15R ␣ on the surface of other DCs to be trans presented to IL-15 -responsive cells. Instead, they suggest a more complicated model of trans presentation.
The studies above focused on the functions of IL-15 and IL-15R ␣ during noninfl amed, homeostatic conditions. TLRs induce the production of both IL-15 and IL-15R ␣ by myeloid cells ( 4 -6, 20 -22 ) . Hence, to understand how endogenous IL-15 and IL-15R ␣ proteins function during infl ammatory responses, we have developed sensitive assays for detecting endogenous IL-15 and IL-15R ␣ proteins. We have used these assays to further examine how these proteins are induced in DCs and how they support NK cell activation.
RESULTS

IL-15, IL-15R ␣ , and complexes of IL-15 -IL-15R ␣ proteins are induced in DCs after TLR stimulation
Analyses of the biology of IL-15 and IL-15R ␣ have been challenging because the potent physiological eff ects of these proteins occur at relatively low levels of expression. To understand how IL-15 and IL-15R ␣ function under physiological circumstances, we fi rst optimized ELISAs for these proteins using recombinant IL-15 and IL-15R ␣ proteins and found that we were able to detect picomolar levels of these proteins (unpublished data). Because IL-15 and IL-15R ␣ bind to each other with high affi nity and may function as a complex in physiological settings, we investigated whether the presence of either protein aff ects the detection of the other. Detection of IL-15R ␣ protein was not aff ected by the presence of IL-15 ( Fig. S1 A, available at http://www.jem.org/cgi/content/ full/jem.20071913/DC1). In contrast, the detection of IL-15 protein was progressively diminished by the presence of increasing amounts of IL-15R ␣ protein (Fig. S1 B) . These results suggest that at least one of the anti -IL-15 antibodies used in our capture ELISA binds to an epitope that is masked when IL-15 binds to IL-15R ␣ . Several commercially available antibodies to IL-15 shared this capacity for interference with IL-15R ␣ binding (unpublished data).
mRNA transcripts for IL-15 and IL-15R ␣ are induced by TLR ligands in DCs, but the translation of these proteins may not follow mRNA levels. We thus measured the levels of IL-15 and IL-15R ␣ proteins before and after stimulation with LPS or poly inosinic -polycytidylic acid (poly I:C). 
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WT DCs co-precipitated signifi cant amounts of IL-15 protein, confi rming that IL-15 -IL-15R ␣ complexes are induced in DCs by TLR stimulation ( Fig. 2 B ) . In contrast, immunoprecipitation of IL-15R ␣ yielded negligible amounts of coprecipitated IL-15 in resting WT DCs, or LPS-stimulated IL-15 Ϫ / Ϫ DCs and IL-15R ␣ Ϫ / Ϫ DCs ( Fig. 2 B and unpublished data). Importantly, IL-15 was not co-precipitated with IL-15R ␣ from 1:1 mixtures of LPS-stimulated IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ DCs ( Fig. 2 B ) . Therefore, IL-15 and IL-15R ␣ must be coordinately expressed by the same cells to form IL-15 -IL-15R ␣ complexes -even under infl ammatory conditions during which both proteins are induced.
IL-15 -IL-15R
␣ complexes are preassembled in DCs in the absence of protein secretion IL-15 protein is not effi ciently produced in IL-15R ␣ Ϫ / Ϫ cells ( Fig. 1 B ) . One mechanism by which IL-15R ␣ could facilitate the production of IL-15 would be if IL-15R ␣ directly bound newly synthesized IL-15 before being secreted (e.g., used as a " capture " antibody and an anti -IL-15R ␣ antibody was used as a " detection " reagent (Fig. S1 C) . We used this complex ELISA to measure the levels of IL-15 -IL-15R ␣ complexes in cell lysates from BMDCs. IL-15 -IL-15R ␣ complexes were induced by poly I:C in WT BMDCs but not in IL-15 Ϫ / Ϫ BMDCs or IL-15R ␣ Ϫ / Ϫ BMDCs ( Fig. 1 D ) . The kinetics of IL-15 -IL-15R ␣ complex induction was very similar to the induction of IL-15 and IL-15R ␣ proteins. Collectively, these studies suggest that IL-15 and IL-15R ␣ proteins are induced in BMDCs by TLR ligands and exist largely in IL-15 -IL-15R ␣ complexes. ( Fig. 2 A ) . IL-15 -IL-15R ␣ complexes were predictably absent from stimulated IL-15 Ϫ / Ϫ cells and IL-15R ␣ Ϫ / Ϫ BMDCs ( Fig. 2 A ) sIL-15R ␣ proteins in supernatants from poly I:C -stimulated BMDCs. These experiments revealed that minimal amounts of IL-15 were induced by poly I:C stimulation in the supernatants of WT BMDCs after 24 ( Fig. 3 A, gray columns) and 48 ( Fig. 3 A, black columns) h, but not in supernatants from IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ cells. Given the interference of IL-15R ␣ with ELISA-mediated detection of IL-15 in cell lysates ( Fig. 1 B ) , we suspected that IL-15 might be present in IL-15 -sIL-15R ␣ protein complexes in these supernatants. We thus boiled these supernatants in the presence of 0.01% SDS before ELISA and found that IL-15 was indeed induced and progressively accumulated in the supernatants from WT but not IL-15 Ϫ / Ϫ cells ( Fig. 3 B ) . Thus, IL-15 is secreted from WT DCs predominantly in the form of IL-15 -sIL-15R ␣ complexes. Importantly, no IL-15 was observed in the supernatants from IL-15R ␣ Ϫ / Ϫ DCs, even after boiling of the supernatants ( Fig. 3 B ) . Thus, IL-15R ␣ is required for the emergence of IL-15 from cells.
Our assays of sIL-15R ␣ levels in supernatants from poly I:Cstimulated DCs show that soluble IL-15R ␣ accumulated in the supernatants from WT cells and was detected at similar levels in the supernatants from IL-15 Ϫ / Ϫ cells ( Fig. 3 C ) . Hence, IL-15 is not required for the production or release of sIL-15R ␣ . To directly examine whether coordinate expression of IL-15 and IL-15R ␣ was required for producing soluble IL-15 -sIL-15R ␣ protein complexes in the supernatants of poly I:Cstimulated DCs, we assayed supernatants of 1:1 mixed cultures of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ DCs for the presence of these complexes. These experiments revealed that IL-15 -sIL-15R ␣ complexes were detected only in the supernatants of WT cells, but not when IL-15 and IL-15R ␣ are produced by separate cells ( Fig. 3 D ) . These results all mirror the fi ndings we obtained in the cellular lysates of BMDCs. Thus, the within the ER or Golgi) and stabilized IL-15 in a complex. To test this possibility, we pretreated BMDCs with brefeldin A (which blocks protein traffi cking through the Golgi) before stimulation with LPS, and then tested lysates of these cells for the presence of IL-15 -IL-15R ␣ complexes. Significant levels of IL-15 -IL-15R ␣ complexes were induced in WT cells even in the presence of brefeldin A ( Fig. 2 C ) . No IL-15R ␣ protein was observed on the surface of these cells by fl ow cytometry, and no soluble IL-15R ␣ (sIL-15R ␣ ) was detected in supernatants, confi rming that brefeldin A blocked the emergence of IL-15R ␣ from the Golgi complex (Fig. S2 , A and B, available at http://www.jem.org/cgi/content/full/ jem.20071913/DC1). Thus, IL-15R ␣ appears to bind IL-15 during biogenesis. Brefeldin A may also block the traffi cking of proteins from recycling and/or late endosomes to the plasma membrane. To eliminate the possibility that brefeldin A exclusively unveiled recycling complexes in these experiments, we treated DCs with LPS plus cycloheximide, which should block the formation of nascent IL-15 -IL-15R ␣ complexes but should not block recycling complexes, and then asked whether IL-15 -IL-15R ␣ complexes were induced. These experiments revealed that cycloheximide prevented the formation of IL-15 -IL-15R ␣ complexes, suggesting that the complexes we detect in LPS plus brefeldin A -treated DCs are newly synthesized ( Fig. 2 C ) .
Like many transmembrane and secreted proteins, IL-15 undergoes N-linked glycosylation in the ER, a form that is sensitive to EndoH digestion ( 23 ) . N-linked sugars are removed from IL-15 in the Golgi during further processing so that mature forms of IL-15 are resistant to EndoH. To determine whether IL-15 -IL-15R ␣ complexes may be assembled when IL-15 bears EndoH-sensitive N-linked sugars during biogenesis, we asked whether IL-15 that co-precipitated with IL-15R ␣ from LPS-stimulated DCs is EndoH sensitive. LPSstimulated DCs were lysed in NP-40 lysis buff er, immunoprecipitated with anti -IL-15R ␣ antibodies, and treated with either EndoH or buff er alone before immunoblotting analysis for IL-15 expression. These experiments revealed that EndoH treatment of anti -IL-15R ␣ -immunoprecipitated lysates produces a novel IL-15 -specifi c band at ‫ف‬ 12.7 kD, corresponding to un-glycosylated IL-15 ( Fig. 2 D ) . Therefore, native IL-15 -IL-15R ␣ complexes contain EndoH-sensitive IL-15, indicating that these complexes form in the ER or early Golgi before the completion of Golgi processing.
TLR-stimulated DCs release soluble IL-15 -sIL-15R ␣ protein complexes
To follow the fate of IL-15 -IL-15R ␣ complexes after Golgi processing, we studied the expression of these proteins on the cell surface of stimulated DCs. Emergence of IL-15R ␣ protein onto the surface of DCs occurs normally in the absence of IL-15, but emergence of IL-15 requires IL-15R ␣ (Fig. S3 , available at http://www.jem.org/cgi/content/full/ jem.20071913/DC1). IL-15 may be secreted from cells, and a soluble form of IL-15R ␣ (sIL-15R ␣ ) can be released from cells ( 24, 25 ) . Accordingly, we studied the levels of IL-15 and ( Fig. 5 B ) . It was not technically feasible to perform ELISA analyses on boiled sera samples and thereby quantitate IL-15 protein samples in complexes. However, ELISAs revealed that IL-15 -sIL-15R ␣ complexes are induced only in WT mice ( Fig. 5 C ) . Thus, similar to our fi ndings with cultured BMDCs, soluble complexes of IL-15 and sIL-15R ␣ are induced by TLR stimulation in vivo.
diff erences in IL-15, IL-15R ␣ , and IL-15 -IL-15R ␣ protein levels are likely due to diff erences in protein production rather than diff erences in recycling or secretion from the cells.
Coordinate expression of IL-15 and IL-15R ␣ by DCs is required for supporting NK cell activation in vitro
Our prior studies indicated that IL-15R ␣ expression on DCs is required for NK cell activation ( 20 ) . As IL-15 signaling in splenic DCs has been suggested to support their maturation, we fi rst examined the activation of WT, IL-15 Ϫ / Ϫ , and IL-15R ␣ Ϫ / Ϫ BMDCs ( 26 ) . Stimulation of BMDCs with poly I:C led to modestly reduced levels of IL-12 production and normal levels of CD40 and CD86 up-regulation ( Fig. 4, A and B ) . Thus, TLR-triggered activation of BMDCs proceeds largely normally in the absence of either IL-15 or IL-15R ␣ .
To determine whether coordinated expression of IL-15 and IL-15R ␣ by DCs is required for activating NK cells, we stimulated WT, IL-15 Ϫ / Ϫ , IL-15R ␣ Ϫ / Ϫ , or a 1:1 mixture of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ BMDCs with poly I:C and cocultured these cells with NK cells. We then assayed NK cell activation in these cultures by testing the supernatants of these cultures for the production of IFN-␥ by ELISA. These studies revealed that IFN-␥ was secreted in signifi cant amounts only in cultures containing WT BMDCs and not in cultures from IL-15 Ϫ / Ϫ , IL-15R ␣ Ϫ / Ϫ , or a mixture of these DCs ( Fig.  4 C ) . Flow cytometric analyses of these NK cells revealed that NK cells from all poly I:C -stimulated cultures up-regulated expression of the surface activation marker CD69 ( Fig.  4 D ) . However, only NK cells co-cultured with WT DCs expressed signifi cant levels of intracellular IFN-␥ and intracellular granzyme B, indicating that these cells were fully activated and armed with cytotoxic granules ( Fig. 4, D and E ) . Thus, coordinate expression of IL-15 and IL-15R ␣ in DCs is required for NK cell activation, and the failure of mixtures of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ BMDCs to form IL-15 -IL-15R ␣ complexes leads to a failure of these cells to fully activate NK cells.
sIL-15R ␣ and IL-15 -sIL-15R ␣ complexes are induced in the sera of stimulated mice Multiple cell types may be able to respond to TLR ligands and elaborate IL-15 and IL-15R ␣ . To determine whether the mechanisms that we have elucidated in DCs apply to physiological responses in vivo, we studied the expression of IL-15, sIL-15R ␣ , and IL-15 -sIL-15R ␣ complexes in the serum of resting and poly I:C -stimulated mice by ELISA. These experiments revealed that negligible levels of IL-15 and IL-15R ␣ are present in the sera of resting mice. 24 h after stimulation with poly I:C, sIL-15R ␣ was detected at similarly high levels in the serum of WT and IL-15 Ϫ / Ϫ mice, but not in IL-15R ␣ Ϫ / Ϫ mice ( Fig. 5 A ) . Similar results were obtained with LPS stimulation (unpublished data). Thus, sIL-15R ␣ is physiologically released into the sera from TLRstimulated mice. Minimal levels of soluble IL-15 were detected in the serum of poly I:C -treated WT mice, and no appreciable IL-15 was found in the sera from IL-15 Ϫ / Ϫ mice ion to cultured BMDCs. Therefore, the cell biology we have defi ned in BMDCs is an accurate refl ection of physiological IL-15 -sIL-15R ␣ production in vivo.
Coordinate expression of IL-15 and IL-15R ␣ by hematopoeitic cells is required for supporting NK cell activation in vivo To determine whether coordinated expression of IL-15 and IL-15R ␣ is also required for activating NK cells in vivo, we tested the ability of the radiation chimera mice described above to activate NK cells. Consistent with our prior studies, only mice reconstituted with WT HSCs possessed appreciable numbers of NK cells ( 14, 18, 19 ) . To have comparable NK cells to assay, we purifi ed NK cells from RAG-1 Ϫ / Ϫ mice, labeled them with CFSE, and adoptively transferred these labeled NK cells into the radiation chimera before stimulating the mice with poly I:C (see experimental design, Fig. 6 A ) . Production of IFN-␥ and granzyme B by the adoptively transferred NK cells was assayed by fl ow cytometry 6 and 12 h later, respectively. Importantly, although adoptively transferred (CFSE + ) NK cells were stimulated to express CD69 in all poly I:C -stimulated mice, NK cells only expressed significant amounts of IFN-␥ and granzyme B in WT mice ( Fig. 6 , B and C ). Thus, the failure of mixtures of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ hematopoietic cells to form IL-15 -sIL-15R ␣ complexes correlates with a failure of these chimeric mice to activate NK cells in vivo. BMDCs with poly I:C, after which supernatants of the four types of cultures were exchanged between cultures. NK cells were subsequently co-cultured with BMDCs and the exchanged supernatants, after which IFN-␥ production was measured by ELISA. These studies revealed that poly I:Cstimulated WT DCs activated NK cells regardless of the type of supernatant present, whereas no other DCs or mixtures of DCs were able to activate NK cells ( Fig. 7 ) . In contrast, soluble IL-15 -sIL-15R ␣ complexes found in WT supernatants did not augment NK cell activation any better than supernatants lacking these complexes ( Fig. 7 ) . Moreover, soluble IL-15 -sIL-15R ␣ complexes in supernatants of poly I:C -stimulated WT BMDCs were unable to support NK cell activation in the presence of IL-15 Ϫ / Ϫ or IL-15R ␣ Ϫ / Ϫ DCs ( Fig. 7 ) . Similar results were obtained with LPS stimulation (unpublished data). Thus, membrane-bound IL-15 -IL-15R ␣ complexes are the critical mediators of IL-15 -mediated NK cell activation. Meanwhile, soluble IL-15 -sIL-15R ␣ complexes are unable to either augment membrane-bound complexes or compensate for the lack of membrane-bound complexes.
We then asked whether a mixture of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ hematopoietic cells could generate IL-15 -sIL-15R ␣ complexes in vivo after TLR stimulation. To address this question, we fi rst interbred IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ mice to generate double-mutant mice. These double-mutant mice phenotypically resemble both IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ mice, reinforcing the idea that IL-15 and IL-15R ␣ function together and do not perform signifi cant functions independently from each other (unpublished data). We irradiated these double-mutant mice and reconstituted them with WT, IL-15 Ϫ / Ϫ , IL-15R ␣ Ϫ / Ϫ , or a 1:1 mixture of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ hematopoietic stem cells (HSCs). 6 wk after reconstitution, we stimulated these mice with poly I:C and assayed their sera for the presence of IL-15, IL-15R ␣ , and IL-15 -sIL-15R ␣ complex proteins after 24 h by ELISA. These experiments revealed that modest levels of IL-15 were induced in chimeras reconstituted with WT cell HSCs, but not in the other chimera ( Fig. 5 E ) . sIL-15R ␣ was detected at signifi cant levels in the sera of both WT and IL-15 Ϫ / Ϫ HSCreconstituted chimera, and at roughly half these levels when IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ HSCs were mixed at 1:1 ( Fig. 5 D ) . Importantly, IL-15 -sIL-15R ␣ complexes were detected only in the sera of poly I:C -stimulated chimera reconstituted with WT cells and not in chimera reconstituted with a mixture of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ HSCs ( Fig. 5 F ) . Collectively, these results suggest that hematopoietic cells in intact mice regulate IL-15 and IL-15R ␣ production in a similar fash- 
IL-15 that emerges from normal DCs does not bind to IL-15R ␣ on neighboring DCs
Free IL-15 has been reported in certain pathological conditions, and soluble recombinant IL-15 can be added to cells and bind to IL-15R ␣ . Hence, an additional question is whether IL-15 -IL-15R ␣ complexes that emerge onto cell surfaces dissociate at an appreciable rate to release free soluble IL-15 that can bind to IL-15R ␣ on other cells. To address this question, we stimulated 1:1 mixtures of congenic CD45.1 + WT DCs and either CD45. ( Fig. 8 A , panels 5 and 6, and Fig. S5 ). Thus, IL-15 that emerges from WT cells is not released in appreciable amounts to bind to contiguous, neighboring cells.
To further examine whether IL-15 -IL-15R ␣ complexes on the surface of DCs might release free soluble IL-15 protein, even if transiently, we tested the ability of an anti -IL-15
Membrane-bound IL-15 -IL-15R ␣ complexes, rather than soluble IL-15 -sIL-15R ␣ complexes, support NK cell activation ex vivo
To determine whether membrane-bound or soluble IL-15 -sIL-15R ␣ complexes support NK cell activation ex vivo, we tested whether serum containing these complexes could support NK cell activation. We generated radiation chimera in which IL-15 Ϫ / Ϫ IL-15R ␣ Ϫ / Ϫ double-mutant mice were reconstituted with WT, IL-15 Ϫ / Ϫ , IL-15R ␣ Ϫ / Ϫ , or a 1:1 mixture of IL-15 Ϫ / Ϫ and IL-15R ␣ Ϫ / Ϫ HSCs. 24 h after stimulation with poly I:C, IL-15 -sIL-15R ␣ complexes were present only in the sera of WT HSC -reconstituted chimera, consistent with our fi ndings above ( Fig. 5 ) . We incubated this undiluted serum with purifi ed NK cells in vitro for 6 h and assayed the NK cells for expression of CD69 and intracellular IFN-␥ . These studies showed that serum from poly I:Cstimulated mice caused NK cells to express CD69 but did not induce IFN-␥ expression (Fig. S4 , available at http:// www.jem.org/cgi/content/full/jem.20071913/DC1). Reinforcing our fi ndings above with supernatants from activated BMDCs ( Fig. 7 ) , these studies indicate that membrane-bound cent studies have suggested that both IL-15 and DCs are critical for NK cell activation in vivo ( 20, 22 ) . However, these studies leave open the possibility that IL-15 and DCs might independently support NK cell activation in vivo. For example, IL-15 might be produced by macrophages to stimulate DCs to activate NK cells in vivo. To more directly investigate whether IL-15R ␣ expression by DCs mediates NK cell activation in vivo, we reconstituted irradiated IL-15 Ϫ / Ϫ IL-15R ␣ Ϫ / Ϫ double-mutant mice with a 1:1 mixture of HSCs from CD11c -diphtheria toxin (DT) receptor (CD11c-DTR) transgenic mice and HSCs from either WT or IL-15R ␣ Ϫ / Ϫ mice. After hematopoietic reconstitution, DT was injected into the chimera to transiently eliminate DCs. 24 h later, mice were injected with poly I:C. Finally, 6 h later, the status of CD11cHi DCs and the activation of NK cells were studied by fl ow cytometry (see experimental scheme, Fig. 9 A ) . These experiments revealed that DT eliminated approximately half of the CD11cHi DCs in chimera reconstituted with a 1:1 mixture of CD11c-DTR and other HSCs ( Fig. 9 B ) . The remaining CD11cHi DCs expressed IL-15R ␣ after poly I:C stimulation in chimera reconstituted with WT HSCs and did not express IL-15R ␣ in chimera reconstituted with IL-15R ␣ Ϫ / Ϫ HSCs ( Fig. 9 C ) . Thus, this experiment created chimeric mice in which IL-15R ␣ Ϫ / Ϫ DCs could be compared directly to IL-15R ␣ + DCs in their ability to activate NK cells.
Turning to NK cell activation in these chimera, we found that NK cells up-regulated CD69 in all poly I:C -stimulated mice, so both WT and IL-15R ␣ Ϫ / Ϫ DCs support this initial step of NK cell activation ( Fig. 9 D ) . In contrast, WT DCs stimulated much greater numbers of NK cells to produce IFN-␥ when compared with IL-15R ␣ Ϫ / Ϫ DCs ( Fig. 9 D , compare second to third columns). Mice bearing a mixture of CD11c-DTR and IL-15R ␣ Ϫ / Ϫ DCs also supported NK cell production of IFN-␥ in the absence of DT ( Fig. 9 D , compare third to fourth columns). Parallel experiments performed with chimeric mice reconstituted with mixtures of CD11c-DTR and either WT or IL-15 Ϫ / Ϫ HSCs revealed similar results, i.e., IL-15 Ϫ / Ϫ DCs are also unable to activate NK cells in vivo ( Fig. 9 E ) . Therefore, DCs must express both IL-15 and IL-15R ␣ to activate NK cells under physiological conditions.
DISCUSSION
Our current studies reveal a novel cell biological mechanism by which IL-15 is coexpressed with IL-15R ␣ in DCs after TLR stimulation and binds IL-15 within the ER -Golgi complex. Plasma membrane-bound IL-15 -IL-15R ␣ complexes are highly stable complexes that do not release appreciable amounts of free IL-15 to neighboring IL-15R ␣ -bearing cells. These membrane-bound complexes trans present IL-15 to responsive cells during cell -cell contact, mediating the critical stimulatory signal to NK cells. Soluble IL-15 -sIL-15R ␣ complexes are released from the cell surface, but these complexes fail to provide agonistic signals. We have coupled these cell biological studies with in vivo studies that have confi rmed the physiological validity of our experiments with cultured DCs. Finally, we have demonstrated that IL-15R ␣ monoclonal antibody that binds only free IL-15 to compete with the formation of membrane IL-15 -IL-15R ␣ complexes on the surface of poly I:C -stimulated DCs. We incubated progressively higher doses of anti -IL-15 antibody with WT DCs at the same time that they were stimulated with poly I:C and measured the amount of membrane-bound IL-15 after 24 h. These experiments revealed that the number of DCs expressing surface IL-15 and the intensity of surface staining were unchanged by doses of anti -IL-15 antibody of up to 25 μ g/ml ( Fig. 8 B ) . Hence, negligible amounts of membrane-bound IL-15 are released by membrane IL-15R ␣ . Therefore, physiologically induced IL-15 -IL-15R ␣ complexes on DC surfaces do not dissociate at appreciable rates.
IL-15R ␣ expression on DCs is essential for NK cell activation in vivo
Our recent work showed that IL-15R ␣ expression by DCs is essential for DC-mediated NK cell activation in vitro, and re- expression specifi cally on DCs plays an essential role in supporting NK cell activation in mice. As membrane-bound IL-15R ␣ -IL-15 complexes on DCs appear to play a dominant role in supporting NK cell activation in vivo, these studies highlight the notion that cytokine signals may be delivered by specifi c cell types in cell contact -dependent fashion.
IL-15R ␣ , a chaperone for IL- 15 We have found that EndoH-sensitive forms of IL-15 are bound to IL-15R ␣ in LPS-stimulated DCs, and that IL-15 -IL-15R ␣ complexes can be found in brefeldin A -treated but not cycloheximide-treated cells. Considered together with our discovery that DCs must express IL-15R ␣ to secrete IL-15, it is likely that IL-15R ␣ binds to IL-15 and stabilizes this protein in the ER and/or Golgi apparatus. Such complexes probably prevent free IL-15 from undergoing ER-associated protein degradation, a well-established process by which " misfolded " proteins in the ER are proteolyzed in ubiquitinand proteosome-dependent processes ( 27 ) . Recycling and trans presentation of these membrane-bound complexes may then stimulate responding cells ( 14 ) . Hence, our results suggest that IL-15R ␣ functions both as an intracellular chaperone for IL-15 as well as an extracellular scaff old that presents IL-15 to responsive cells.
We have shown that IL-15 -IL-15R ␣ complexes that emerge onto the surface of DCs fail to release soluble IL-15 to neighboring IL-15R ␣ -expressing DCs. These surprising observations suggest that IL-15 -IL-15R ␣ complexes on DC surfaces are highly stable, a fi nding consistent with the high affi nity of IL-15R ␣ for IL-15 ( ‫ف‬ 5 × 10 Ϫ 11 M) ( 8 ) . Thus, although heterologous IL-15 can be added to IL-15R ␣ -expressing cells, form cell surface complexes, and stimulate IL-15 -dependent responses, the physiological production and trans presentation of IL-15 by DCs appears to predominantly involve IL-15 -IL-15R ␣ complexes that form intracellularly during biosynthesis and remain intact for prolonged periods (e.g., 24 h) ( 17 ) .
Preassembly of IL-15 -IL-15R ␣ protein complexes in DCs explains a requirement for coordinate expression of IL-15 and IL-15R ␣ to support NK cell activation
Our fi nding that IL-15 -IL-15R ␣ complexes are preassembled within DCs provides an explanation for why coordinate expression of these molecules is required for NK cell activation sIL-15R ␣ complex and the membrane-bound IL-15 -IL-15R ␣ complex. Alternatively, membrane-bound IL-15 -IL-15R ␣ complexes may possess a competitive advantage over soluble IL-15 -sIL-15R ␣ complexes due to the increased local concentration or valency of membrane-bound complexes during cell -cell contact.
The failure of endogenous soluble IL-15 -sIL-15R ␣ complexes to activate NK cells can also be contrasted with recent studies indicating that certain cytokine-specifi c antibodies can form complexes with their cognate cytokines, stabilize cytokines, and amplify the immunological eff ects of these cytokines ( 29 -31 ) . There are multiple diff erences between antibody -cytokine complexes and receptor -cytokine complexes. For example, diff erent anti -IL-15 antibodies or forms of IL-15R ␣ may interfere with IL-15 binding to IL-2/15R ␤ and ␥ c receptors. In addition, antibodies, but not soluble cytokine receptors, can also bind to Fc receptors on multiple cells. Recent structural studies of IL-15 and IL-15R ␣ proteins have revealed important insights into how these proteins interact and should facilitate future investigations into how such receptor -cytokine complexes diff er from antibody -cytokine complexes ( 32 ) . Combining these biochemical insights with the divergent biological properties of these complexes should facilitate future attempts to engineer these proteins for therapeutic benefi t ( 33, 34 ) .
DCs require IL-15R ␣ to trans present IL-15 to NK cells during NK cell activation
We have used mixed radiation chimera to selectively unveil the role of IL-15R ␣ expression by DCs during NK cell activation in vivo. Our fi ndings extend our prior work that IL-15R ␣ on BMDCs is critical for activating NK cells in vitro ( 20 ) . Our current fi ndings are also consistent with a recent study using both IL-15 Ϫ / Ϫ mice and CD11c-DTR mice to show that both IL-15 and DCs are required for NK cell activation in vivo ( 22 ) . By using mixed radiation chimera generated from both IL-15R ␣ Ϫ / Ϫ and CD11c-DTR HSCs, we have extended the prior work to show that IL-15R ␣ expression specifi cally on DCs mediates NK cell activation in vivo. ( 35, 36 ) . In this regard, DC activation of NK cells broadly resembles DC activation of naive T cells, during which an immunological synapse constitutes a sophisticated cell contact -dependent activation mechanism. Indeed, direct evidence for a DC -NK cell synapse directing IL-15 signaling to NK cells has recently been reported ( 37 ) .
Recent structural studies have revived the notion that IL-2R ␣ may trans present IL-2 ( 38 -40 ) . Although IL-2 signals clearly perform distinct biological functions from IL-15 in vitro and in vivo. Coordinate expression of IL-15 and IL-15R ␣ by DCs is required for the formation of IL-15 -IL-15R ␣ complexes and the activation of NK cells in vitro and in vivo after TLR stimulation. This result parallels prior fi ndings that coordinate expression of these molecules is necessary to perform IL-15 -dependent homeostatic functions in resting mice ( 18, 19 ) . Hence, the cell biology of IL-15 and IL-15R ␣ interactions during infl ammatory conditions resembles the homeostatic condition.
In addition to identifying intracellular complexes of IL-15 and IL-15R ␣ , we have identifi ed soluble extracellular IL-15 -sIL-15R ␣ complexes that are released from DCs after TLR stimulation. A prior study described the presence of soluble IL-15R ␣ in the serum of resting mice, and proposed that IL-15R ␣ could be proteolytically cleaved from the cell surface ( 24 ) . Our current experiments extend and contrast with the prior results in two respects. First, we fi nd that the production and release of soluble sIL-15R ␣ is induced by TLR stimulation, rather than being constitutively present at high levels (e.g., 40 ng/ml) in resting C57BL/6J strain mice ( 24 ) . Second, we fi nd that the majority of soluble IL-15R ␣ is complexed with IL-15. Therefore, although free IL-15 is not released from DCs, soluble IL-15 -sIL-15R ␣ complexes, which may represent IL-15 bound to a proteolytic product of IL-15R ␣ , are released into solution.
Our Although the physiological functions of soluble IL-15 -sIL-15R ␣ complexes are unclear, it is important to note that these complexes are neither agonistic nor antagonistic in our DC -NK cell co-culture assays ( Fig. 7 A ) . In this regard, nonagonsitic soluble IL-15 -sIL-15R ␣ complexes contrast with agonistic soluble IL-6 -IL-6R complexes ( 28 ) . This observation provides important clues about their function. If soluble complexes bound to IL-2/15R ␤ / ␥ c receptors as well as membrane-bound complexes, one might expect them to display either agonist or antagonist activities (via competitive inhibition). Thus, soluble IL-15 -sIL-15R ␣ complexes may not bind well to cell surface IL-2/15R ␤ receptors on cell surfaces under physiological circumstances. This failure of IL-15 -sIL-15R ␣ complexes to bind IL-2/15R ␤ receptors could be due to diff erences between the structures of the soluble IL-15 -For DC-mediated activation of NK cells in vitro, 2 × 10 5 /ml BMDCs were cultured for 24 h in the presence of 1 μ g/ml LPS or 25 μ g/ml poly I:C, followed by incubation with 10 5 /ml NK cells as described previously ( 20 ) . Surface IL-15 expression was detected using biotinylated anti -IL-15 antibody (PeproTech). IL-15R ␣ expression on cell surfaces was detected by using biotinylated anti -IL-15R ␣ antibody BAF551 (R & D Systems) as described previously ( 15 ) . IFN-␥ and granzyme B production by NK cells was determined by intracellular cytokine staining as described previously (Caltag and eBioscience) ( 12 ) . Cell surface expression of NK1.1, CD69, CD40, CD86, CD11b, CD11c, and I-A b was performed using commercial antibodies (BD Biosciences). Cells were analyzed with an LSR II cytometer (Becton Dickinson) and FloJo software.
Detection of endogenous IL
Online supplemental material. Fig. S1 shows the detection of IL-15 and IL-15R ␣ proteins and the IL-15 -IL-15R ␣ complex. In Fig. S2 , brefeldin A treatment blocks the emergence of IL-15R ␣ onto the surface of cells or into the supernatants of DCs. Fig. S3 shows the expression of IL-15 and sIL-15R ␣ proteins on the cell surface of TLR-stimulated BMDCs. Fig. S4 shows that soluble IL-15 complexed with sIL-15R ␣ fails to activate NK cells ex vivo. In Fig. S5 , IL-15 that emerges from normal DCs does not bind to IL-15R ␣ on neighboring DCs. The online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20071913/DC1. signals in vivo, and although IL-2R ␣ has not shown the capacity to bind and trans present IL-2 in vivo, directed cytokine presentation may nevertheless be a feature of IL-15, IL-2, and perhaps other cytokines ( 7, 10, 38, 41, 42 ) . This mode of cell contact -dependent delivery of cytokine signals would greatly restrict the cells that receive cytokine signals. Finally, given the rapidity with which memory CD8 + T cells are reactivated in vivo, the requirement for DCs to reactivate memory CD8 + T cells, the selective expression of IL-2/15R ␤ receptors by these cells, and the IL-15 dependence of these cells, it is possible that memory CD8 + T cell reactivation involves a similar IL-15 -dependent activation event mediated by DCs ( 43 ) .
In summary, we have shown that IL-15 and IL-15R ␣ are preformed as complexes in DCs in response to TLR stimulation. IL-15 -IL-15R ␣ complexes progress to the DC surface where they deliver critical activating signals to NK cells during cell -cell contact. IL-15 -IL-15R ␣ complexes that are cleaved from the surface of DCs may be byproducts of a termination mechanism for this potent stimulus. This novel series of cell biological events refi nes our understanding of IL-15R ␣ -mediated trans presentation, and highlights how the immune system delivers cytokine signals in a highly regulated and cell type -and geographically restricted fashion.
MATERIALS AND METHODS
Mice, radiation chimera, adoptive transfers, and in vivo DC ablation. IL-15R ␣ Ϫ / Ϫ (R ␣ KO) mice were described previously ( 10 ) . All strains were backbred to a C57B1/6J background for at least 12 generations. IL-15 Ϫ / Ϫ (15KO) and RAG-1 Ϫ / Ϫ mice on a C57BL/6J background were purchased from Taconic Laboratories. CD11c-DTR transgenic mice were purchased from The Jackson Laboratory ( 44 ) . Double-mutant IL-15 Ϫ / Ϫ IL-15R ␣ Ϫ / Ϫ (15KO/R ␣ KO) mice were generated by interbreeding in our facility. Radiation bone marrow chimeras were produced as described previously, except that mixed 15KO:R ␣ KO, CD11c-DTR:WT, and CD11c-DTR:R ␣ KO radiation chimera were generated by using mixtures (1:1) of bone marrow cells from congenic donors of the indicated genotypes of mice ( 18 ) . All mice were used between the ages of 6 and 12 wk of age. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of California, San Francisco.
For in vivo stimulation experiments, mice were injected intraperitoneally with 10 g/kg LPS (Sigma-Aldrich) or 25 g/kg poly I:C (GE Healthcare). For adoptive transfer experiments, NK cells were purifi ed from the spleens of RAG-1 Ϫ / Ϫ mice by adherence and magnetic bead depletion of myeloid cells, and in some experiments, labeled with CFSE before intravenous injection into recipient mice as described previously ( 18 ) . In vivo depletion of CD11c Ϫ DTR + DCs was performed using a single injection of 2 -4 μ g/kg body weight of DT (EMD) ( 44 ) .
In vitro DC preparations and assays. BMDCs were generated in culture as described previously ( 18 ) . The purity of BMDC cultures was checked by analyzing an aliquot of each culture for surface expression of CD11c and CD11b by fl ow cytometry (BD Biosciences). Splenic DCs were enriched by digesting spleens with 2.5 mg/ml collagenase B (Boehringer Mannheim) and 0.3 mg/ml DNase I (Sigma-Aldrich), followed by isolation on percoll gradients as described previously ( 18 ) . TLR stimulation of DCs was performed with either 1 μ g/ml LPS or 25 μ g/ml poly I:C. To inhibit protein secretion, BMDCs were treated with Golgi Plug (brefeldin A; BD Biosciences) during the LPS stimulation per the manufacturer ' s instructions. To inhibit protein synthesis, BMDCs were treated with 10 μ g/ml cycloheximide during LPS stimulation.
